Bristol Myers Squibb and Takeda Collaborate to Accelerate AI-Based Drug Discovery
A key development set to change the pharmaceutical research landscape occurred this morning, with Bristol Myers Squibb (BMS) and Takeda Pharmaceuticals announcing plans to share their respective proprietary data to facilitate AI-based drug discovery. This partnership, announced on October 1, 2025, aims to leverage the power of AI to accelerate...
